Use of loop diuretics in patients with chronic heart failure: an observational overview.
Niels Tb ScholteDilan AydinGerard Cm LinssenStefan KoudstaalPhilip C RademakerPeter R GeerlingsMarco Wf van GentIsmail AksoyLiane OosteromEric BoersmaHans-Peter Brunner-La RoccaJasper J BrugtsPublished in: Open heart (2023)
In this large registry of real-world HF patients, LD use was highest among HFrEF patients. Advanced symptoms, diabetes mellitus and worse renal function were significantly associated with a higher diuretic dose regardless of left ventricular ejection fraction.
Keyphrases
- ejection fraction
- aortic stenosis
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- heart failure
- peritoneal dialysis
- type diabetes
- coronary artery disease
- transcription factor
- adipose tissue
- acute coronary syndrome
- patient reported outcomes
- atrial fibrillation
- transcatheter aortic valve replacement
- insulin resistance
- aortic valve
- hypertrophic cardiomyopathy